KEGG   DISEASE: Familial breast-ovarian cancer
Entry
H02531                      Disease                                
Name
Familial breast-ovarian cancer
  Subgroup
Hereditary breast ovarian cancer syndrome (HBOC)
Description
Hereditary susceptibility to breast cancer is considered to be polygenic. The most important breast cancer susceptibility genes are BRCA1 and BRCA2. Mutations in these genes confer a high risk of early-onset breast cancer and also an increased risk of ovarian cancer. Recently, mutations in RAD51C and RAD51D were identified in families with breast and ovarian cancer.
Category
Cancer
Brite
Human diseases in ICD-11 classification [BR:br08403]
 02 Neoplasms
  Malignant neoplasms, except primary neoplasms of lymphoid, haematopoietic, central nervous system or related tissues
   Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic, central nervous system or related tissues
    Malignant neoplasms of breast
     2C65  Hereditary breast and ovarian cancer syndrome
      H02531  Familial breast-ovarian cancer
Pathway-based classification of diseases [BR:br08402]
 Replication and repair
  nt06506  Double-strand break repair
   H02531  Familial breast-ovarian cancer
  nt06508  Interstrand crosslink repair
   H02531  Familial breast-ovarian cancer
Pathway
hsa03440  Homologous recombination
hsa03460  Fanconi anemia pathway
Network
nt06506 Double-strand break repair
nt06508 Interstrand crosslink repair
Gene
(BROVCA1) BRCA1 [HSA:672] [KO:K10605]
(BROVCA2) BRCA2 [HSA:675] [KO:K08775]
(BROVCA3) RAD51C [HSA:5889] [KO:K10870]
(BROVCA4) RAD51D [HSA:5892] [KO:K10871]
(BROVCA5) PALB2 [HSA:79728] [KO:K10897]
Other DBs
ICD-11: 2C65
MeSH: D061325
OMIM: 604370 612555 613399 614291 620442
Reference
  Authors
Welcsh PL, King MC
  Title
BRCA1 and BRCA2 and the genetics of breast and ovarian cancer.
  Journal
Hum Mol Genet 10:705-13 (2001)
DOI:10.1093/hmg/10.7.705
Reference
PMID:7545954 (BROVCA1)
  Authors
Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett LM, Ding W, et al.
  Title
A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.
  Journal
Science 266:66-71 (1994)
DOI:10.1126/science.7545954
Reference
PMID:8524414 (BROVCA2)
  Authors
Wooster R, Bignell G, Lancaster J, Swift S, Seal S, Mangion J, Collins N, Gregory S, Gumbs C, Micklem G
  Title
Identification of the breast cancer susceptibility gene BRCA2.
  Journal
Nature 378:789-92 (1995)
DOI:10.1038/378789a0
Reference
PMID:21616938 (BROVCA3)
  Authors
Pelttari LM, Heikkinen T, Thompson D, Kallioniemi A, Schleutker J, Holli K, Blomqvist C, Aittomaki K, Butzow R, Nevanlinna H
  Title
RAD51C is a susceptibility gene for ovarian cancer.
  Journal
Hum Mol Genet 20:3278-88 (2011)
DOI:10.1093/hmg/ddr229
Reference
PMID:21822267 (BROVCA4)
  Authors
Loveday C, Turnbull C, Ramsay E, Hughes D, Ruark E, Frankum JR, Bowden G, Kalmyrzaev B, Warren-Perry M, Snape K, Adlard JW, Barwell J, Berg J, Brady AF, Brewer C, Brice G, Chapman C, Cook J, Davidson R, Donaldson A, Douglas F, Greenhalgh L, Henderson A, Izatt L, Kumar A, Lalloo F, Miedzybrodzka Z, Morrison PJ, Paterson J, Porteous M, Rogers MT, Shanley S, Walker L, Eccles D, Evans DG, Renwick A, Seal S, Lord CJ, Ashworth A, Reis-Filho JS, Antoniou AC, Rahman N
  Title
Germline mutations in RAD51D confer susceptibility to ovarian cancer.
  Journal
Nat Genet 43:879-882 (2011)
DOI:10.1038/ng.893
Reference
PMID:17200668 (BROVCA5)
  Authors
Rahman N, Seal S, Thompson D, Kelly P, Renwick A, Elliott A, Reid S, Spanova K, Barfoot R, Chagtai T, Jayatilake H, McGuffog L, Hanks S, Evans DG, Eccles D, Easton DF, Stratton MR
  Title
PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene.
  Journal
Nat Genet 39:165-7 (2007)
DOI:10.1038/ng1959
LinkDB

» Japanese version

DBGET integrated database retrieval system